Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank65
3Y CAGR-26.2%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-26.2%/yr
Quarterly compound
Percentile
P65
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.36% |
| Q3 2025 | 0.83% |
| Q2 2025 | 32.94% |
| Q1 2025 | -26.37% |
| Q4 2024 | 7.13% |
| Q3 2024 | 15.49% |
| Q2 2024 | 18.94% |
| Q1 2024 | -30.94% |
| Q4 2023 | 5.62% |
| Q3 2023 | 10.53% |
| Q2 2023 | 14.53% |
| Q1 2023 | -31.70% |
| Q4 2022 | 25.75% |
| Q3 2022 | 3.02% |
| Q2 2022 | 12.70% |
| Q1 2022 | -29.24% |
| Q4 2021 | -33.40% |
| Q3 2021 | -42.02% |
| Q2 2021 | 24.15% |
| Q1 2021 | -8.26% |
| Q4 2020 | -91.60% |
| Q3 2020 | -17.34% |
| Q2 2020 | 4.73% |
| Q1 2020 | 0.00% |